TW358109B - Stabilized ophthalmically compatible compositions and method of stabilizing polymer compositions the invention relates to stabilized ophthalmically compatible compositions and method of stabilizing polymer compositions - Google Patents

Stabilized ophthalmically compatible compositions and method of stabilizing polymer compositions the invention relates to stabilized ophthalmically compatible compositions and method of stabilizing polymer compositions

Info

Publication number
TW358109B
TW358109B TW084113926A TW84113926A TW358109B TW 358109 B TW358109 B TW 358109B TW 084113926 A TW084113926 A TW 084113926A TW 84113926 A TW84113926 A TW 84113926A TW 358109 B TW358109 B TW 358109B
Authority
TW
Taiwan
Prior art keywords
compositions
stabilized
ophthalmically compatible
stabilizing polymer
polymer compositions
Prior art date
Application number
TW084113926A
Other languages
English (en)
Chinese (zh)
Inventor
Fu-Pao Tsao
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Application granted granted Critical
Publication of TW358109B publication Critical patent/TW358109B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00—Use of organic ingredients
    • C08K5/49—Phosphorus-containing compounds
    • C08K5/51—Phosphorus bound to oxygen
    • C08K5/53—Phosphorus bound to oxygen bound to oxygen and to carbon only
    • C08K5/5317—Phosphonic compounds, e.g. R—P(:O)(OR')2

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Dental Preparations (AREA)
TW084113926A 1995-06-22 1995-12-27 Stabilized ophthalmically compatible compositions and method of stabilizing polymer compositions the invention relates to stabilized ophthalmically compatible compositions and method of stabilizing polymer compositions TW358109B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/493,761 US5683993A (en) 1995-06-22 1995-06-22 Compositions and methods for stabilizing polymers

Publications (1)

Publication Number Publication Date
TW358109B true TW358109B (en) 1999-05-11

Family

ID=23961593

Family Applications (1)

Application Number Title Priority Date Filing Date
TW084113926A TW358109B (en) 1995-06-22 1995-12-27 Stabilized ophthalmically compatible compositions and method of stabilizing polymer compositions the invention relates to stabilized ophthalmically compatible compositions and method of stabilizing polymer compositions

Country Status (13)

Country Link
US (2) US5683993A (cg-RX-API-DMAC7.html)
EP (1) EP0833609B1 (cg-RX-API-DMAC7.html)
JP (3) JP4260881B2 (cg-RX-API-DMAC7.html)
AT (1) ATE208189T1 (cg-RX-API-DMAC7.html)
AU (1) AU715686B2 (cg-RX-API-DMAC7.html)
CA (1) CA2222646C (cg-RX-API-DMAC7.html)
CY (1) CY2323B1 (cg-RX-API-DMAC7.html)
DE (1) DE69616791T2 (cg-RX-API-DMAC7.html)
DK (1) DK0833609T3 (cg-RX-API-DMAC7.html)
ES (1) ES2167581T3 (cg-RX-API-DMAC7.html)
PT (1) PT833609E (cg-RX-API-DMAC7.html)
TW (1) TW358109B (cg-RX-API-DMAC7.html)
WO (1) WO1997000669A1 (cg-RX-API-DMAC7.html)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6274634B1 (en) * 1997-05-14 2001-08-14 Senju Pharmaceutical Co., Ltd. Aqueous suspension preparations with excellent redispersibility
DK0893121T3 (da) * 1997-06-27 2002-06-17 Akzo Nobel Nv Flydende oral medicinopløsning
DE19744113A1 (de) * 1997-10-06 1999-04-15 Mann Gerhard Chem Pharm Fab Dexamethason-Gel
EP0938896A1 (en) * 1998-01-15 1999-09-01 Novartis AG Autoclavable pharmaceutical compositions containing a chelating agent
US5885550A (en) * 1998-07-02 1999-03-23 Vallier; Deandra K. Ophthalmic whitening solution
US6627660B1 (en) * 1999-11-16 2003-09-30 New River Pharmaceuticals Inc. Stabilized thyroxine compounds
EP2042594B1 (en) 2000-11-17 2011-03-23 Kyowa Hakko Kirin Co., Ltd. Expression of xenogenous (human) immunoglobulins in cloned, transgenic ungulates
CA2458126C (en) * 2001-11-21 2012-06-26 Novartis Ag Composition for stabilizing hyaluronic acid
US20040115160A1 (en) * 2002-12-13 2004-06-17 Salamone Joseph C. Quaternary ammonium esters for disinfection and preservation
US20050084468A1 (en) * 2003-10-17 2005-04-21 Colgate-Palmolive Company Antimicrobial cleaning composition
US8466174B2 (en) 2006-03-17 2013-06-18 Johnson & Johnson Vision Care, Inc. Methods for stabilizing oxidatively unstable compositions
JP5160757B2 (ja) * 2006-09-01 2013-03-13 ホーユー株式会社 毛髪脱染剤組成物
US20100021561A1 (en) * 2006-09-21 2010-01-28 Chowhan Masood A Self-preserved aqueous pharmaceutical compositions
TWI394564B (zh) * 2006-09-21 2013-05-01 Alcon Res Ltd 自行保存型水性藥學組成物
US8388941B2 (en) * 2006-09-28 2013-03-05 Alcon Research, Ltd. Self preserved aqueous pharmaceutical compositions
JP5216596B2 (ja) * 2006-10-26 2013-06-19 千寿製薬株式会社 眼科用水性液剤
CA2682100C (en) 2007-03-28 2017-11-21 University Of Iowa Research Foundation Transgenic animal models of disease
US8759321B2 (en) 2007-06-13 2014-06-24 Bausch & Lomb Incorporated Ophthalmic composition with hyaluronic acid and polymeric biguanide
US8119112B2 (en) 2008-01-31 2012-02-21 Bausch & Lomb Incorporated Ophthalmic compositions with an amphoteric surfactant and hyaluronic acid
DK2308466T3 (en) * 2008-03-17 2017-09-11 Novartis Ag Aqueous pharmaceutical compositions containing borate-polyol complexes
WO2010135731A1 (en) * 2009-05-22 2010-11-25 Kaufman Herbert E Preparations and methods for ameliorating or reducing presbyopia
US8299079B2 (en) 2009-05-22 2012-10-30 Kaufman Herbert E Preparations and methods for ameliorating or reducing presbyopia
TWI489997B (zh) 2009-06-19 2015-07-01 Alcon Res Ltd 含有硼酸－多元醇錯合物之水性藥學組成物
MX383372B (es) 2011-05-16 2025-03-13 Univ Missouri Animales resistentes al virus del sindrome reproductivo y respiratorio porcino.
WO2013067328A1 (en) 2011-11-03 2013-05-10 University Of Iowa Research Foundation Transgenic pig models of cystic fibrosis
US20130177599A1 (en) * 2012-01-06 2013-07-11 Insite Vision Incorporated Methods and kits for extending contact lens use
KR101400791B1 (ko) 2012-10-04 2014-05-29 주식회사대성미생물연구소 동물용 복합 기능성 항생제 조성물
WO2016187426A1 (en) 2015-05-19 2016-11-24 Amorphex Therapeutics Llc A device that delivers a sustained low-dose of a myopia-suppressing drug
US10231961B1 (en) 2017-02-07 2019-03-19 Genus Lifesciences Inc. Pharmaceutical compositions and methods of using the same
US10413505B1 (en) 2017-02-07 2019-09-17 Genus Lifesciences Inc. Pharmaceutical compositions and methods of using the same
US10149843B1 (en) 2017-02-07 2018-12-11 Gneus Lifescineces Inc. Pharmaceutical compositions and methods of using the same
CN109387622A (zh) * 2018-03-02 2019-02-26 国家纳米科学中心 一种高分子材料表面修饰方法及其应用

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2322883A1 (de) * 1973-05-07 1974-11-28 Roehm Gmbh Wasserloesliche polymerisate
DE2743764C2 (de) * 1977-09-29 1982-07-22 Hoechst Ag, 6000 Frankfurt Wäßrige Kunststoffdispersion auf Basis von Vinylpolymeren
DE2810348A1 (de) * 1978-03-10 1979-09-20 Hoechst Ag Waessrige kunststoffdispersion auf basis von vinylpolymeren
US4303568A (en) * 1979-12-10 1981-12-01 Betz Laboratories, Inc. Corrosion inhibition treatments and method
US4474916A (en) * 1982-07-27 1984-10-02 Basf Aktiengesellschaft Concentrated aqueous solutions of mixtures of organic complexing agents and dispersing agents based on polymeric aliphatic carboxylic acids
EP0163696B1 (en) * 1983-11-14 1992-11-25 Columbia Laboratories, Inc. Use of a bioadhesive
JPS60184013A (ja) * 1984-03-01 1985-09-19 Yoshitomi Pharmaceut Ind Ltd 点眼剤
US4540738A (en) * 1984-12-07 1985-09-10 The Kendall Company Acrylic adhesive composition comprising an alpha amino phosphonic acid or salt having improved stability
US4889689A (en) * 1986-10-14 1989-12-26 Ciba-Geigy Corporation Method of disinfecting a soft contact lens with a diethylene triamine penta(methylenephosphonic acid) stabilized hydrogen peroxide solution
US4900469A (en) * 1986-10-21 1990-02-13 The Clorox Company Thickened peracid precursor compositions
US4812173A (en) * 1987-05-01 1989-03-14 Ciba-Geigy Corporation Stabilized hydrogen peroxide contact lens disinfecting solution
US5192535A (en) * 1988-02-08 1993-03-09 Insite Vision Incorporated Ophthalmic suspensions
DE3805663A1 (de) * 1988-02-24 1989-09-07 Henkel Kgaa Oxaalkanpolyphosphonsaeuren, ihre verwendung als thresholder sowie diese verbindungen enthaltende, komplexierend wirkende zusammensetzungen
EP0706802B1 (en) * 1988-08-04 2004-03-24 Novartis AG A method of preserving ophthalmic solutions and compositions therefor
US4960799A (en) * 1988-09-13 1990-10-02 Ciba-Geigy Corporation Stabilized aqueous solutions of pharmaceutically acceptable salts of ortho-(2,6-dichlorophenyl)-aminophenylacetic acid for opthalmic use
US5075104A (en) * 1989-03-31 1991-12-24 Alcon Laboratories, Inc. Ophthalmic carboxy vinyl polymer gel for dry eye syndrome
US5034556A (en) * 1989-04-03 1991-07-23 Ppg Industries, Inc. Reaction products of alpha-aminomethylene phosphonic acids and epoxy compounds and their use in coating compositions
US5300296A (en) * 1989-11-06 1994-04-05 Frank J. Holly Antimicrobial agent for opthalmic formulations
WO1992008685A1 (fr) * 1990-11-14 1992-05-29 L'oreal Composes amphiphiles non-ioniques derives du glycerol, leur procede de preparation, composes intermediaires correspondants et compositions contenant lesdits composes
AU653768B2 (en) * 1990-12-27 1994-10-13 Advanced Medical Optics, Inc. Method and composition for disinfecting contact lenses
JP3107873B2 (ja) * 1991-09-26 2000-11-13 ユニ・チャーム株式会社 高吸水性ポリマーの経時着色防止方法および経時着色防止剤
NO303146B1 (no) * 1991-11-26 1998-06-02 Eniricerche Spa Vandig geldannende blanding og anvendelse derav
JP2873530B2 (ja) * 1991-12-13 1999-03-24 参天製薬株式会社 ニュートン型粘性を示すカルボキシビニルポリマー含有点眼液基剤
DE4209722C3 (de) * 1992-03-25 1997-06-19 Medproject Pharma Entwicklungs Tropfbares Gel für die Augenheilkunde
SE500660C2 (sv) * 1992-12-03 1994-08-01 Mo Och Domsjoe Ab Förfarande för framställning av grönlut vid kemikalieåtervinning i sulfat- och sulfitmassafabriker
US5340572A (en) * 1993-02-08 1994-08-23 Insite Vision Incorporated Alkaline ophthalmic suspensions
DE59407521D1 (de) * 1993-08-10 1999-02-04 Ciba Geigy Ag Mercerisiernetzmittel
FR2726762B1 (fr) * 1994-11-10 1997-01-17 Oreal Composition cosmetique ou dermatologique sous forme d'une dispersion d'une phase huileuse dans une phase aqueuse stabilisee a l'aide de particules de gel cubique et son procede d'obtention
US5603929A (en) * 1994-11-16 1997-02-18 Alcon Laboratories, Inc. Preserved ophthalmic drug compositions containing polymeric quaternary ammonium compounds

Also Published As

Publication number Publication date
US5683993A (en) 1997-11-04
EP0833609B1 (en) 2001-11-07
PT833609E (pt) 2002-04-29
ES2167581T3 (es) 2002-05-16
CA2222646C (en) 2009-12-08
DE69616791D1 (de) 2001-12-13
JPH11510480A (ja) 1999-09-14
AU715686B2 (en) 2000-02-10
EP0833609A1 (en) 1998-04-08
US5858996A (en) 1999-01-12
CY2323B1 (en) 2003-11-14
JP2012153710A (ja) 2012-08-16
DE69616791T2 (de) 2002-05-29
AU6355196A (en) 1997-01-22
DK0833609T3 (da) 2002-02-18
JP4260881B2 (ja) 2009-04-30
CA2222646A1 (en) 1997-01-09
WO1997000669A1 (en) 1997-01-09
JP2008248246A (ja) 2008-10-16
ATE208189T1 (de) 2001-11-15

Similar Documents

Publication Publication Date Title
TW358109B (en) Stabilized ophthalmically compatible compositions and method of stabilizing polymer compositions the invention relates to stabilized ophthalmically compatible compositions and method of stabilizing polymer compositions
PL344048A1 (en) Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
AU7523294A (en) Concentrated liquid or gel dishwashing detergent composition containing calcium xylene sulfonate
AU3567295A (en) Pharmaceutical preparation containing metformin and a process for producing it
BG103485A (en) Ketobanzamides as calpain inhibitors
DK0975235T3 (da) Ernæringssammensætninger indeholdende oligosaccharider
WO2002008296A8 (de) Alkoxysilylgruppenhaltige bindemittel und bindemittelzusammensetzungen, verfahren zu deren herstellung und deren verwendung
AP9801222A0 (en) Proatease inhibitors.
AU1532588A (en) Stabilized hydrogen peroxide solution
AU2928995A (en) Polyalkoxyl terpene derivatives and compositions containing same
HK79390A (en) Pharmaceutical compositions containing pharmacologically active biphosphonates
CA2315767A1 (en) Autoclavable pharmaceutical compositions containing a chelating agent
HK42291A (en) Oral compositions
CA2279200A1 (en) Anaesthetic bone cement
CA2278133A1 (en) Fluoroether compositions and methods for inhibiting their degradation in the presence of a lewis acid
BG101714A (en) Improvements in the function of the endometrium or in functions related to it
MY127953A (en) Gabapentin-containing solid compositions and process for preparing the same
MY115071A (en) Efficacy enhancer for agricultural chemicals and agricultural chemical compositions
AU7675896A (en) Sulfur containing di-tert-butylphenol compounds useful as anti-inflammatory agents
IL108856A0 (en) Hydroxymethyl-furazancarboxylic acid derivatives, their preparation and pharmaceutical compositions containing them
AU6132499A (en) Novel mercaptans and disulfides
CA2127374A1 (fr) Nouveau derive de l'isoindolinone, sa preparation et les compositions pharmaceutiques qui le contiennent
ES8802576A1 (es) Un procedimiento para fabricar un articulo de una composicion fotopolimerizable
AU2801395A (en) Bleaching compositions
WO1996001788A3 (en) Amino acid-derived diaminopropanols

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees